Are Statistical Analysis Plans “required” for Pivotal Studies? [General Sta­tis­tics]

posted by Achievwin – US, 2023-02-15 13:07 (41 d 19:31 ago) – Posting: # 23467
Views: 539

❝ Dear colleagues, we are conducting a pivotal fed-fasted BE study versus a reference listed drug (RLD).

Here is my opinion:

Essentially it is your study and you have to defend the submission, it is your prerogative to have what you want. - CRO gets most of their money when they deliver draft report (study pass/fail)

If it is a complex study - you have to predefine critical steps in the SAP (before the sample analysis start- to avoid any claims of Bias).

If it is a study against the product specific guidance and logical analysis is easy to understand you can refer to the FDA guidance(s) in the protocol.

Complete thread:

UA Flag
 Admin contact
22,557 posts in 4,724 threads, 1,607 registered users;
27 visitors (0 registered, 27 guests [including 12 identified bots]).
Forum time: 09:38 CEST (Europe/Vienna)

The function of genius is not to give new answers, but to pose
new questions which time and mediocrity can resolve.    H.R. Trevor-Roper

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz